Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma
Even though the IMDC system scores them equally, we concluded that each parameter might express dissimilarities on survival; some might even lack any significant effect. Furthermore, factors such as serum albumin and uric acid levels, the presence of specific organ metastases, or the number of metastatic sites might affect survival more than the IMDC parameters. Further studies are needed to predict prognosis and develop a treatment plan using an individualized risk score that includes molecular biomarkers, imaging findings, and patient clinical characteristics.
Authors
- Kayhan Ertürk (ORCID: https://orcid.org/0000-0001-5804-6800)
- Mert Erciyestepe (ORCID: https://orcid.org/0000-0002-7590-6101)
- Muhammed Mustafa Atçı (ORCID: https://orcid.org/0000-0002-1300-3695)
- Emir Çelik (ORCID: https://orcid.org/0000-0001-8440-3082)
- Şermin Dinç Sonuşen (ORCID: https://orcid.org/0009-0003-0624-1462)
- Gülhan Dinç (ORCID: https://orcid.org/0009-0007-6025-7800)
- Ahmet Emin Öztürk (ORCID: https://orcid.org/0000-0003-3365-5540)
- Kemal Akkaya
- Okan Aydın (ORCID: https://orcid.org/0000-0002-9516-992X)
- Tuğçe Kübra Güneş (ORCID: https://orcid.org/0000-0002-7917-2459)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Liv Hospital (TR)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/17520363.2025.2589382
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00